It has long been recognized that schizophrenia-like pathology is also expressed at attenuated levels in individuals with schizotypal or schizoid personality traits,
1 and mild attenuated paranoid delusional thinking and auditory hallucinations are observed in up to 30% of the general population.
2 There is consistent evidence that these attenuated psychotic symptoms (APSs) may be construed as an expression of liability for schizophrenia and related disorders,
3-9 just as higher but borderline abnormal levels of blood pressure or glucose express higher liability for metabolic and cardiovascular disease.
10 This interpretation is supported by studies showing a link between APSs and nonaffective psychotic
3,11-14 and, to a lesser extent, other psychiatric disorders.
15,16